Efficacy of antacids for cisplatin-induced gastrointestinal symptoms in the treatment of lung cancer
Int. Journal of Clinical Pharmacology and Therapeutics · 2023
DOI: 10.5414/cp204349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2023. Verfasst von Osamu Taniguchi und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antineoplastic Agents, Lung Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Taniguchi, O., Saito, Y., Takekuma, Y., Akita, H., Kinoshita, I., Shimizu, Y., Shinagawa, N., & Sugawara, M. (2023). Efficacy of antacids for cisplatin-induced gastrointestinal symptoms in the treatment of lung cancer. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204349
Vancouver
Taniguchi O, Saito Y, Takekuma Y, Akita H, Kinoshita I, Shimizu Y, et al. Efficacy of antacids for cisplatin-induced gastrointestinal symptoms in the treatment of lung cancer. Int. Journal of Clinical Pharmacology and Therapeutics. 2023. doi:10.5414/cp204349
BibTeX
@article{Taniguchi2023,
author = {Taniguchi, Osamu and Saito, Yoshitaka and Takekuma, Yoh and Akita, Hirotoshi and Kinoshita, Ichiro and Shimizu, Yasushi and Shinagawa, Naofumi and Sugawara, Mitsuru},
title = {Efficacy of antacids for cisplatin-induced gastrointestinal symptoms in the treatment of lung cancer},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
doi = {10.5414/cp204349}
}
EUVIMED